2005 TRIPS amendment on public health (Article 31bis)
E616453
TRIPS Agreement amendment
World Trade Organization rule change
international intellectual property law instrument
The 2005 TRIPS amendment on public health (Article 31bis) is a World Trade Organization rule change that allows countries to export patented medicines made under compulsory licenses to nations lacking sufficient pharmaceutical manufacturing capacity, in order to improve access to essential drugs.
All labels observed (1)
| Label | Occurrences |
|---|---|
| 2005 TRIPS amendment on public health (Article 31bis) canonical | 1 |
Statements (47)
| Predicate | Object |
|---|---|
| instanceOf |
TRIPS Agreement amendment
ⓘ
World Trade Organization rule change ⓘ international intellectual property law instrument ⓘ |
| addresses | public health problems affecting developing and least-developed countries ⓘ |
| adoptedBy | World Trade Organization General Council NERFINISHED ⓘ |
| adoptionDate | 2005-12-06 ⓘ |
| allows |
export of patented medicines produced under compulsory licences
ⓘ
regional trade agreements of developing or least-developed countries to use the system jointly ⓘ |
| alsoKnownAs |
Article 31bis of the TRIPS Agreement
NERFINISHED
ⓘ
TRIPS public health amendment NERFINISHED ⓘ |
| appliesTo | WTO member states NERFINISHED ⓘ |
| beneficiariesInclude |
least-developed country WTO members
ⓘ
other WTO members with insufficient or no pharmaceutical manufacturing capacity ⓘ |
| concerns |
access to medicines in developing countries
ⓘ
compulsory licensing of pharmaceutical patents ⓘ |
| createsExceptionTo | requirement that production under compulsory licence be predominantly for the supply of the domestic market ⓘ |
| criticizedFor |
complex procedural requirements
ⓘ
limited practical use by WTO members ⓘ |
| designedTo | balance patent protection with public health needs ⓘ |
| enteredIntoForce | 2017-01-23 ⓘ |
| entryIntoForceCondition | acceptance by two-thirds of WTO members ⓘ |
| field |
global public health policy
ⓘ
intellectual property law ⓘ international trade law ⓘ |
| implementedBy | Annex to the TRIPS Agreement on the implementation of Article 31bis NERFINISHED ⓘ |
| influenced | national legislation on compulsory licensing for export in several WTO members ⓘ |
| legalBasisFor | export of pharmaceutical products made under compulsory licence ⓘ |
| legalForm | amendment to Annex 1C of the WTO Agreement ⓘ |
| linkedTo | Doha Declaration on the TRIPS Agreement and Public Health NERFINISHED ⓘ |
| modifies | Article 31 of the TRIPS Agreement ⓘ |
| originatesFrom | 2003 WTO General Council Decision on the Implementation of Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public Health NERFINISHED ⓘ |
| partOf |
Agreement on Trade-Related Aspects of Intellectual Property Rights
NERFINISHED
ⓘ
World Trade Organization legal framework ⓘ |
| permits | importation of generics produced under compulsory licence from other WTO members ⓘ |
| purpose |
to implement the 2001 Doha Declaration on the TRIPS Agreement and Public Health
ⓘ
to improve access to essential medicines in countries with insufficient or no pharmaceutical manufacturing capacity ⓘ |
| replaces | 2003 WTO waiver on exports of medicines under compulsory licence ⓘ |
| requires |
measures to prevent re-exportation of products supplied under the system
ⓘ
notification to the WTO by exporting members granting compulsory licences under the system ⓘ notification to the WTO by importing members using the system ⓘ publication of information about quantities and destinations of products supplied under the system ⓘ remuneration to patent holders by exporting members granting compulsory licences ⓘ special labelling or marking of products supplied under the system ⓘ |
| scope | pharmaceutical products needed to address public health problems ⓘ |
| subjectOf |
WTO notifications by importing and exporting members
ⓘ
debates on access to medicines and intellectual property ⓘ interpretative discussions in the WTO TRIPS Council ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
Doha Declaration on the TRIPS Agreement and Public Health
→
influenced
→
2005 TRIPS amendment on public health (Article 31bis)
ⓘ